134 related articles for article (PubMed ID: 9797481)
1. Human osteoclast formation and activity in vitro: effects of alendronate.
Breuil V; Cosman F; Stein L; Horbert W; Nieves J; Shen V; Lindsay R; Dempster DW
J Bone Miner Res; 1998 Nov; 13(11):1721-9. PubMed ID: 9797481
[TBL] [Abstract][Full Text] [Related]
2. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
3. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
5. The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro.
Neale SD; Haynes DR; Howie DW; Murray DW; Athanasou NA
J Arthroplasty; 2000 Aug; 15(5):654-62. PubMed ID: 10960005
[TBL] [Abstract][Full Text] [Related]
6. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
7. Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.
Zimolo Z; Wesolowski G; Rodan GA
J Clin Invest; 1995 Nov; 96(5):2277-83. PubMed ID: 7593614
[TBL] [Abstract][Full Text] [Related]
8. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
9. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
10. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
13. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
Hodge JM; Kirkland MA; Aitken CJ; Waugh CM; Myers DE; Lopez CM; Adams BE; Nicholson GC
J Bone Miner Res; 2004 Feb; 19(2):190-9. PubMed ID: 14969388
[TBL] [Abstract][Full Text] [Related]
14. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
16. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
Lees RL; Heersche JN
J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
[TBL] [Abstract][Full Text] [Related]
17. [Effects of L-threonate on bone resorption by osteoclasts in vitro].
He JH; Tong NW; Li HQ; Wu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):225-8. PubMed ID: 15807273
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of bone resorption in breast carcinoma.
Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
[TBL] [Abstract][Full Text] [Related]
20. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
